Xiong Y, Mahmood A, Meng Y, Zhang Y, Zhang ZG, Morris DC, et al
Eli Lilly (LLY): Eli Lilly meanwhile has several ongoing studies for both its active products as well as next-generation assets in its pipeline
team utilized NAPA as a MALDI platform (Figure c) with ultra-trace sensitivity and molecular imaging capabilities to analyze the spatial and size distributions of polyhydroxybutyric acid, polyglutamic acid, and polysaccharide oligomers in soybean root nodule sections
On November 26, 2024, the Centers for Medicare & Medicaid Services (CMS) proposed expanding Medicare Part D and Medicaid to cover weight loss drugs
Podsumowanie: BPC-157 i KPV s rozpatrywane jako obiecujce peptydy z potencjaem zastosowania w medycynie, szczeglnie w dziedzinie zdrowia jelitowego i zarzdzania stanami zapalnymi